Recruiting HIV AIDS Studies in Berkley
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absorbed, modified, distributed, and removed from the bo...
A Clinical Trial of STP0404 in Adults With HIV-1 Infection
The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in adult participants living with Human Immunodeficiency Virus Type 1 (HIV-1) infec...
About HIV AIDS Clinical Trials in Berkley
HIV (human immunodeficiency virus) attacks the immune system and, if untreated, can lead to AIDS (acquired immunodeficiency syndrome). Antiretroviral therapy (ART) can control the virus and prevent transmission. Research continues to pursue a functional cure, long-acting therapies, and preventive vaccines.
There are currently 2 hiv aids clinical trials recruiting participants in Berkley, MI. These studies are seeking a combined 336 participants. Research is being sponsored by Gilead Sciences, ST Pharm Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
HIV AIDS Clinical Trials in Berkley — FAQ
Are there hiv aids clinical trials in Berkley?
Yes, there are 2 hiv aids clinical trials currently recruiting in Berkley, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Berkley?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Berkley research site will contact you about next steps.
Are clinical trials in Berkley free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Berkley studies also compensate for your time and travel.
What hiv aids treatments are being tested?
The 2 active trials in Berkley are testing new therapies including novel drugs, biologics, and treatment approaches for hiv aids.
Data updated March 2, 2026 from ClinicalTrials.gov